James Kuiken
Directeur/Membre du Conseil chez COLUMBIA FINANCIAL, INC.
Fortune : 216 758 $ au 30/04/2024
Profil
James M.
Kuiken has worked as an Independent Non-Executive Director at Columbia Financial, Inc. since 2020 and as an Operations Director at Roche Molecular Systems, Inc. since 1996.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
COLUMBIA FINANCIAL, INC.
0,01% | 15/04/2024 | 12 864 ( 0,01% ) | 216 758 $ | 30/04/2024 |
Postes actifs de James Kuiken
| Sociétés | Poste | Début |
|---|---|---|
| COLUMBIA FINANCIAL, INC. | Directeur/Membre du Conseil | 22/05/2020 |
Roche Molecular Systems, Inc.
 Roche Molecular Systems, Inc. Medical/Nursing ServicesHealth Services Roche Molecular Systems, Inc. develops and produces molecular-based diagnostic tests and automated testing platforms. It specializes in oncology, virology, microbiology and blood screening tests areas. The firm's customers include researchers, physicians, patients, hospitals, laboratories and blood banks. The company is headquartered in Pleasanton, CA. | Directeur des opérations | 01/04/2014 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| COLUMBIA FINANCIAL, INC. | Finance |
| Entreprise privées | 1 |
|---|---|
Roche Molecular Systems, Inc.
Roche Molecular Systems, Inc. Medical/Nursing ServicesHealth Services Roche Molecular Systems, Inc. develops and produces molecular-based diagnostic tests and automated testing platforms. It specializes in oncology, virology, microbiology and blood screening tests areas. The firm's customers include researchers, physicians, patients, hospitals, laboratories and blood banks. The company is headquartered in Pleasanton, CA. | Health Services |